These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2918499)

  • 1. Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
    Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Remuzon P; Weber A; Oki T; Masuyoshi M
    J Med Chem; 1989 Mar; 32(3):537-42. PubMed ID: 2918499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.
    Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Kiechel JR; Remuzon P; Weber A; Oki T; Masuyoshi M; Kessler RE
    J Med Chem; 1990 May; 33(5):1344-52. PubMed ID: 2329555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoronaphthyridines and -quinolones as antibacterial agents. 5. Synthesis and antimicrobial activity of chiral 1-tert-butyl-6-fluoro-7-substituted-naphthyridones.
    Di Cesare P; Bouzard D; Essiz M; Jacquet JP; Ledoussal B; Kiechel JR; Remuzon P; Kessler RE; Fung-Tomc J; Desiderio J
    J Med Chem; 1992 Oct; 35(22):4205-13. PubMed ID: 1433222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoronaphthyridines and -quinolones as antibacterial agents. 3. Synthesis and structure-activity relationships of new 1-(1,1-dimethyl-2-fluoroethyl), 1-[1-methyl-1-(fluoromethyl)-2-fluoroethyl], and 1-[1,1-(difluoromethyl)-2-fluoroethyl] substituted derivatives.
    Remuzon P; Bouzard D; Cesare PD; Essiz M; Jacquet JP; Kiechel JR; Ledoussal B; Kessler RE; Fung-Tomc J
    J Med Chem; 1991 Jan; 34(1):29-37. PubMed ID: 1992128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
    Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
    Sanchez JP; Domagala JM; Hagen SE; Heifetz CL; Hutt MP; Nichols JB; Trehan AK
    J Med Chem; 1988 May; 31(5):983-91. PubMed ID: 3361584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids.
    Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Ledoussal B; Remuzon P; Kessler RE; Fung-Tomc J
    J Med Chem; 1992 Feb; 35(3):518-25. PubMed ID: 1738144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of new arylfluoronaphthyridine antibacterial agents.
    Chu DT; Fernandes PB; Claiborne AK; Gracey EH; Pernet AG
    J Med Chem; 1986 Nov; 29(11):2363-9. PubMed ID: 3783594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
    Foroumadi A; Emami S; Hassanzadeh A; Rajaee M; Sokhanvar K; Moshafi MH; Shafiee A
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4488-92. PubMed ID: 16105736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
    Chu DT; Fernandes PB; Claiborne AK; Pihuleac E; Nordeen CW; Maleczka RE; Pernet AG
    J Med Chem; 1985 Nov; 28(11):1558-64. PubMed ID: 3934382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoronaphthyridines as antibacterial agents. 6. Synthesis and structure-activity relationships of new chiral 7-(1-, 3-, 4-, and 6-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)naphthyridine analogues of 7-[(1R,4R)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihy dro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Influence of the configuration on blood pressure in dogs. A quinolone-class effect.
    Remuzon P; Bouzard D; Guiol C; Jacquet JP
    J Med Chem; 1992 Jul; 35(15):2898-909. PubMed ID: 1322990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives.
    Foroumadi A; Firoozpour L; Emami S; Mansouri S; Ebrahimabadi AH; Asadipour A; Amini M; Saeid-Adeli N; Shafiee A
    Arch Pharm Res; 2007 Feb; 30(2):138-45. PubMed ID: 17366732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationships.
    Frigola J; Parés J; Corbera J; Vañó D; Mercè R; Torrens A; Más J; Valentí E
    J Med Chem; 1993 Apr; 36(7):801-10. PubMed ID: 8464033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
    Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of new quinolones containing a 7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl] moiety. Gram-positive agents with excellent oral activity and low side-effect potential.
    Hagen SE; Domagala JM; Gracheck SJ; Sesnie JA; Stier MA; Suto MJ
    J Med Chem; 1994 Mar; 37(6):733-8. PubMed ID: 8145222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro Antibacterial Activity of 7-Substituted-6-Fluoroquinolone and 7-Substituted-6,8-Difluoroquinolone Derivatives.
    Leyva-Ramos S; de Loera D; Cardoso-Ortiz J
    Chemotherapy; 2017; 62(3):194-198. PubMed ID: 28334702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of 6-difluoromethoxy-7-piperazinyl-3-quinolinecarboxylic acid derivatives.
    Krishnan R; Lang SA
    J Pharm Sci; 1988 May; 77(5):458-60. PubMed ID: 3137322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
    Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
    J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.